Cargando…

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder

BACKGROUND: Urothelial carcinoma of the bladder (UCB) is a common cancer of the urinary system. Despite substantial improvements in available treatment options, the survival outcome of patients with advanced UCB is unsatisfactory. Therefore, it is necessary to identify new prognostic biomarkers for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yu, Zhang, Keying, Yang, Fa, Jiao, Dian, Li, Mingyang, Zhao, Xiaolong, Xu, Chao, Liu, Shaojie, Li, Hongji, Shi, Shengjia, Yang, Bo, Yang, Lijun, Han, Donghui, Wen, Weihong, Qin, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635966/ https://www.ncbi.nlm.nih.gov/pubmed/34869004 http://dx.doi.org/10.3389/fonc.2021.771036

Ejemplares similares

CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021)

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)

CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023)

Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer
por: Peng, Shiyuan, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Comparison of (68)Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4–20 ng/ml before the initial biopsy
por: Li, Yu, et al.
Publicado: (2020)

High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway
por: Zhang, Jingliang, et al.
Publicado: (2018)

A novel anti-PSMA human scFv has the potential to be used as a diagnostic tool in prostate cancer
por: Han, Donghui, et al.
Publicado: (2016)

An enhancer RNA-based risk model for prediction of bladder cancer prognosis
por: Xu, Zhicheng, et al.
Publicado: (2022)

Galectin-9 expression predicts poor prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Jiao, Jianhua, et al.
Publicado: (2022)

Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Jiao, Dian, et al.
Publicado: (2019)

The higher levels of self-reported satisfaction, the lower risk of depressive symptoms: Evidence from a nationwide cross-sectional study in China
por: Niu, Zhiping, et al.
Publicado: (2022)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
por: Zhang, Jiayu, et al.
Publicado: (2022)

VEGF, EGFR and PSMA as possible imaging targets of lymph node metastases of urothelial carcinoma of the bladder
por: van der Fels, Christa Anne Maria, et al.
Publicado: (2022)

Single-cell analysis reveals the COL11A1(+) fibroblasts are cancer-specific fibroblasts that promote tumor progression
por: Zhang, Jiayu, et al.
Publicado: (2023)

Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder
por: Luo, Yuzhen, et al.
Publicado: (2018)

The Establishment of New Thresholds for PLND-Validated Clinical Nomograms to Predict Non-Regional Lymph Node Metastases: Using (68)Ga-PSMA PET/CT as References
por: Jiao, Jianhua, et al.
Publicado: (2021)

Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer
por: Shi, Sheng-Jia, et al.
Publicado: (2019)

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Interference in melanoma CD248 function reduces vascular mimicry and metastasis
por: Kuo, Cheng-Hsiang, et al.
Publicado: (2022)

Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer
por: Yang, Huixiang, et al.
Publicado: (2015)

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy
por: Jiang, Yao, et al.
Publicado: (2022)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

Health Tract, No. 248: Weights and Measures
Publicado: (1866)

Gene Expression Profiles Identified Novel Urine Biomarkers for Diagnosis and Prognosis of High-Grade Bladder Urothelial Carcinoma
por: Song, Yuxuan, et al.
Publicado: (2020)

Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP
por: Wei, Ming, et al.
Publicado: (2016)

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
por: Yang, Li, et al.
Publicado: (2021)

Establishment and prospective validation of an SUV(max) cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by (68)Ga-PSMA PET/CT: a real-world study
por: Jiao, Jianhua, et al.
Publicado: (2021)

Genetic testing of 248 Chinese aortopathy patients using a panel assay
por: Yang, Hang, et al.
Publicado: (2016)

Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy
por: Cheng, Wen, et al.
Publicado: (2018)

MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma
por: Ning, Jin-zhuo, et al.
Publicado: (2021)

P248 Fungal meningitis in an immunocompetent individual
por: Ningthoujam, Priyolakshmi, et al.
Publicado: (2022)

The Potential of PSMA as a Vascular Target in TNBC
por: Heesch, Amelie, et al.
Publicado: (2023)

Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy
por: Zhou, Lin, et al.
Publicado: (2016)

Hyperprogression after anti-programmed death-1 therapy in a patient with urothelial bladder carcinoma: A case report
por: Yang, Hong-Yu, et al.
Publicado: (2023)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mqgh7jj95hci7j043h7gdfumfu